Modern pharmacy careers do not always follow a straight line. They are more likely to resemble a carefully organized medication cart: several compartments, plenty of labels, and absolutely no room for careless guessing. Faria Munir, PharmD, MS, BCPS, has developed a professional path connecting clinical pharmacy, health-system leadership, drug information, teaching, medical writing, artificial intelligence research, health equity, and pharmaceutical medical review.
Her career offers a useful look at what pharmacists can do beyond traditional dispensing roles. One day’s work may involve analyzing a clinical study, teaching evidence-based medicine, reviewing educational materials, mentoring a resident, or determining whether an artificial intelligence tool has produced a helpful answer or merely a very confident paragraph.
Who Is Faria Munir, PharmD, MS, BCPS?
Faria M. Munir is a pharmacist, educator, researcher, and medical information professional whose work has focused on turning complicated clinical evidence into accurate, practical communication.
She served as a clinical assistant professor and drug information specialist with the University of Illinois Chicago Retzky College of Pharmacy. Public university materials have also identified her in leadership positions associated with the Drug Information Group, including responsibilities involving residency training, education, medical information content, and professional development.
In June 2026, Munir publicly announced that she had started a new position as a Medical Review Manager at Xeris Pharmaceuticals. She described the role as involving the review of medical and promotional materials, medical communications, and publications. The work emphasizes scientific accuracy, appropriate balance, regulatory compliance, and collaboration with Medical Affairs, Regulatory, Legal, and Commercial teams.
That transition fits naturally with her drug information background. Both fields require professionals to ask demanding questions: Is a claim supported by evidence? Are benefits and risks presented fairly? Is the information current? Will the intended audience understand it? Has anyone checked the footnotes before the slide deck develops a life of its own?
Education and Advanced Pharmacy Training
Pharmaceutical sciences and PharmD education
Munir earned a Bachelor of Science in Pharmaceutical Sciences from The Ohio State University in 2015. She remained at Ohio State to complete her Doctor of Pharmacy degree in 2019.
A PharmD is the professional doctorate used to prepare pharmacists for patient care and medication-related practice in the United States. The curriculum typically combines biomedical science, pharmacotherapy, medication safety, communication, law, ethics, health systems, and supervised clinical experiences.
In other words, professional pharmacy education involves considerably more than learning the names of medications. Pharmacists must determine whether a therapy is appropriate, whether the dose makes sense, whether interactions are likely, how treatment should be monitored, and how the plan fits the needs of an individual patient.
Residency training and a master’s degree
After pharmacy school, Munir completed a combined PGY1/PGY2 Health-System Pharmacy Administration and Leadership residency at The University of Kansas Health System. She also earned a Master of Science in Pharmacy Practice from the University of Kansas in 2021.
This type of residency blends clinical development with operational and leadership training. Areas of experience may include medication-use systems, safety, quality improvement, staff education, informatics, policy development, project management, finance, and organizational change.
Munir later applied that background to research on standardized employee training within a pharmacy enterprise. Her published work on Job Instruction training evaluated a structured method designed to reduce variation and make staff education more consistent. The subject may not sound glamorous, but dependable health care is often built from processes that work correctly on an ordinary Tuesdaynot only when an accreditation surveyor happens to be watching.
Understanding the BCPS Credential
The initials BCPS stand for Board Certified Pharmacotherapy Specialist. The credential is awarded by the Board of Pharmacy Specialties to pharmacists who meet professional eligibility requirements and demonstrate advanced pharmacotherapy knowledge through a specialty examination.
Pharmacotherapy specialists evaluate how medications are selected, administered, monitored, and adjusted across diseases and patient populations. The credential supports a broad understanding of drug therapy rather than limiting the pharmacist to one narrow clinical area.
That broad foundation is particularly valuable in drug information. Clinical questions rarely remain inside tidy categories. One request may involve kidney function, drug interactions, dosing, pregnancy, insurance barriers, evidence quality, and an obscure administration detail that suddenly becomes extremely important at 4:57 p.m.
Work in Drug Information and Evidence-Based Medicine
Munir’s academic career became closely associated with drug information and evidence-based medicine. Drug information specialists locate, evaluate, synthesize, and communicate medication evidence for clinicians, health systems, students, organizations, and patients.
The final product may be a clinical response, literature review, formulary document, educational article, policy recommendation, continuing education program, publication, or strategic medical information resource. Although the formats vary, the basic responsibility remains the same: provide an answer that is accurate, balanced, transparent, and useful.
A broad range of clinical questions
Munir’s drug information work has addressed travel vaccines, pneumococcal vaccination, occupational HIV post-exposure prophylaxis, compounded GLP-1 receptor agonists, clobazam dosing, ketamine guidance, COPD therapies, and public claims involving acetaminophen use during pregnancy.
This variety demonstrates an important feature of the specialty. A drug information pharmacist does not need every answer memorized. Instead, the pharmacist needs a reliable method for defining the question, identifying authoritative sources, comparing evidence, recognizing limitations, and developing a clinically responsible conclusion.
Medication preparation and administration resources
Munir has also contributed to reference publications involving light-sensitive injectable medications and drugs that require filters during preparation or administration. She participated in research evaluating whether commonly used drug information resources provide actionable renal-dosing guidance for nephrotoxic medications.
These projects address details that directly affect medication safety. A drug may have the correct name and dose but still be stored, prepared, filtered, or administered incorrectly. Drug information professionals help bridge the gap between selecting a medication and using it safely in real clinical practice.
Teaching Future Pharmacists
At UIC, Munir taught content related to evidence-based medicine, pharmacy practice, and pharmaceutical care in the United States. She also mentored pharmacy students and residents, participated in curriculum development, and contributed to professional discussions about teaching drug information and literature-evaluation competencies.
Evidence-based medicine education teaches students to move beyond saying, “I found a study.” Learners must determine whether the study was designed well, whether its outcomes matter clinically, whether the comparison was appropriate, and whether the results apply to the patient or decision under consideration.
Students must also learn to examine funding, bias, statistical uncertainty, missing data, and conflicts between different sources. It is a form of healthy skepticismthe productive kind that reads the methods section before becoming emotionally attached to the abstract.
Continuing pharmacy education
Munir has participated in continuing education on emerging clinical and technological topics. In May 2026, a UIC program identified her as a speaker for an activity on GLP-1 receptor agonists in obesity management.
The program addressed drug mechanisms, clinical evidence, dosing and titration, adverse effects, long-term adherence, cost, insurance coverage, misconceptions, and barriers to access. She has also contributed to education on the impact and future of artificial intelligence in health care.
Research on Artificial Intelligence in Pharmacy
Artificial intelligence has become one of the most visible themes in Munir’s recent research. She led a published study evaluating ChatGPT as a tool for answering clinical questions in pharmacy practice.
The topic is important because fluent language can create an illusion of authority. An AI-generated response may sound polished, cite impressive terminology, and still be incomplete, outdated, unsupported, or incorrect. In a clinical environment, a confident error is more than an awkward technological moment; it can influence medication decisions.
Munir’s broader AI-related work has included studies of pharmacists’ perceptions of artificial intelligence, national research involving pharmacy faculty and students, generative AI activities in drug information education, comparisons between AI and faculty grading, and evaluations of clinically focused chatbots.
She has also contributed to professional recommendations concerning responsible AI use in health care. This work considers issues such as accuracy, bias, transparency, privacy, ethical implementation, health equity, and the continued need for human verification.
AI as a tool rather than an unquestioned authority
The theme running through this scholarship is more thoughtful than either “AI will solve everything” or “AI should be banned from the building.” Artificial intelligence may support literature evaluation, education, clinical decision tools, patient communication, and administrative efficiency. However, its outputs must be evaluated against primary research, official labeling, current clinical guidance, and patient-specific information.
Munir was also selected as a guest editor for an International Journal of Pharmacy Practice themed collection on AI-enabled solutions in pharmacy. The collection invites research on clinical decision support, medication safety, literature evaluation, patient engagement, dispensing systems, professional education, and the real-world implementation of emerging technologies.
Medical Misinformation and Scientific Trust
Another important area of Munir’s work involves medical misinformation. She has coauthored professional scholarship on the pharmacist’s role in combating false or misleading health claims and on preparing health-professions learners to identify and reduce the spread of misinformation.
Pharmacists frequently encounter patients at the moment when something seen online collides with an actual treatment decision. A patient may be worried about an exaggerated side effect, interested in an unsupported cure, or considering stopping an important medication because of a viral post.
Correcting misinformation requires more than placing a stack of journal articles on the counter and declaring victory. Effective communication considers why the claim seems believable, whether trust has been damaged, what the person already understands, and how uncertainty can be discussed without sounding evasive.
The most useful response is evidence-based, respectful, understandable, and actionable. It helps the patient decide what to do next rather than simply proving that the health professional owns more references.
Health Equity and Access to Care
Munir has contributed to research and professional writing involving health disparities, cultural and structural barriers, social determinants of health, and equitable access to pharmacy services. Her academic research interests have included staff education, diversity and inclusion initiatives, organizational change, and health care disparities.
This work broadens the focus from the medication to the system surrounding it. A treatment cannot provide its intended benefit when a patient cannot afford it, obtain it, understand it, store it properly, travel to appointments, or incorporate it into daily life.
Insurance restrictions, language barriers, transportation, disability, digital access, health literacy, and mistrust can all influence medication outcomes. Recognizing those factors is not separate from evidence-based care. It is part of determining whether a recommendation can work outside the clean, controlled world of a clinical trial.
Medical Writing and Consumer Health Communication
Beyond academic publications, Munir has written consumer-facing health content across multiple therapeutic areas. Her publicly listed WebMD work includes information about treatments used for HIV, hemophilia B, alopecia areata, cystic fibrosis, phenylketonuria, hidradenitis suppurativa, leukemia, lymphoma, and other conditions.
Writing for health professionals and writing for patients require different approaches even when the underlying evidence is identical. A clinician may need details about trial design, dosing adjustments, statistical outcomes, interactions, and guideline placement. A patient may need to understand what the medicine does, how it is taken, which side effects deserve attention, and what questions to ask at the next appointment.
Good medical communication does not remove important science. It removes unnecessary fog. The goal is not to make the information simplistic but to make it usable.
From Academic Pharmacy to Medical Review
Munir’s move into a Medical Review Manager role represents a change in professional setting rather than a departure from her established expertise. Medical review professionals evaluate whether scientific and promotional communications are accurate, adequately supported, appropriately balanced, and consistent with applicable standards.
The work commonly requires collaboration across medical, regulatory, legal, and commercial functions. That means scientific judgment must be combined with diplomacy, careful documentation, and the ability to explain why changing a seemingly tiny phrase may be necessary.
Munir’s previous experience provides a relevant foundation. Drug information develops literature-evaluation discipline. Teaching strengthens clarity. Health-system leadership builds process awareness. Medical writing encourages audience-centered communication. Research promotes curiosity, while BCPS certification supports broad pharmacotherapy knowledge.
Together, those skills create a practical toolkit for reviewing high-stakes medical content without being hypnotized by an attractive chart, a dramatic headline, or a slide containing so many arrows that it appears to be directing airport traffic.
Experience-Based Lessons From Faria Munir’s Career
The following section draws professional lessons from Munir’s publicly documented education, research, teaching, and career transitions. It does not present invented quotations or claim to describe private experiences.
Build a broad foundation before pursuing a narrow title
Munir’s career demonstrates the value of combining clinical training with leadership, education, research, and communication. Early-career pharmacists may feel pressured to select one permanent identity immediately: clinician, administrator, professor, writer, researcher, or industry professional.
Her path suggests that these skills can reinforce one another. Operational training can make research more practical. Teaching can improve medical writing. Clinical knowledge can strengthen medical review. Leadership experience can help a pharmacist understand how evidence becomes policy and how policy becomes daily practice.
Treat evidence evaluation as a portable skill
The subjects in Munir’s portfolio range from injectable-drug handling and vaccines to obesity therapies, artificial intelligence, misinformation, and health equity. The portable skill across all of them is a disciplined method: define the question, locate the best evidence, evaluate quality, identify uncertainty, consider the audience, and communicate a responsible conclusion.
Professionals who master that process can adapt when treatments, technologies, organizations, and job titles change. Memorized facts eventually become outdated. A strong method remains useful.
Use artificial intelligence with guardrails
Munir’s AI research supports a practical approach of curiosity combined with verification. Generative AI may accelerate brainstorming, summarize material, organize information, or support learning activities. However, speed is not the same as validity.
Clinical users should verify important claims against primary literature, official product information, current guidelines, and patient-specific circumstances. The more confidently an AI system presents an answer, the easier it may be to overlook missing context. That is precisely when professional judgment matters most.
Learn to explain the same evidence twice
A skilled medical communicator should be able to explain one body of evidence to different audiences without distorting it. A specialist may need methodology, statistics, limitations, and comparative evidence. A patient may need practical information about purpose, administration, risks, monitoring, and access.
Munir’s combination of academic drug information and consumer health writing illustrates why audience awareness is not decorative. It is part of accuracy. Information that cannot be understood cannot be used reliably.
Connect medication expertise with real-world access
Clinical research helps determine whether a therapy can work under studied conditions. Health equity asks who can realistically benefit from it. Munir’s work on disparities, structural barriers, misinformation, and access highlights the need to consider cost, insurance, language, transportation, disability, trust, and health literacy.
A technically correct recommendation that ignores these realities may be perfect only on paper. Effective pharmacy practice connects scientific evidence with the patient’s actual circumstances.
Let teaching sharpen professional judgment
Teaching requires experts to reveal the reasoning behind their conclusions. A learner who repeatedly asks “Why?” may uncover an assumption that an experienced professional no longer notices.
Mentoring students and residents can therefore improve the teacher’s own decision-making. Explaining study quality, applicability, bias, and uncertainty builds habits that transfer directly to research, medical writing, clinical consultation, and promotional review.
View career transitions as skill translation
The transition from academic drug information to pharmaceutical medical review may appear dramatic, but the underlying competencies are closely related. Teaching represents public speaking, curriculum design, technical explanation, and feedback. Drug information represents literature searching, risk assessment, concise writing, and decision support.
Describing experience by function rather than job title can reveal career opportunities that might otherwise remain hidden. A professional does not discard earlier experience during a transition; the professional translates it into a new setting.
